Chapter 141 Coagulation Disorders Flashcards

1
Q

Top three most common causes of DIC

A

Bacterial sepsis
Malignancy / Acute promyelocytic leukemia
Abruptio placentae, dead fetus syndrome, amniotic fluid embolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Severe form of DIC affecting predominantly young children following viral and bacterial infections, presenting as thrombosis of extensive areas of the skin?

A

Purpura fulminans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Central mechanism of DIC?

A

Uncontrolled generation of thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Proinflammatory cytokines that play central roles in mediating coagulation defects in DIC?

A

IL-6

TNF alpha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is bleeding in chronic DIC different from acute DIC?

A

Discrete bleeding and restricted to skin or mucosal surfaces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The most sensitive test for DIC is:

A

Fibrin degradation products level

Fragmented red cells (schistocytes) in blood smear + elevated FDP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Most common differential diagnosis for DIC that present similarly?

A

Severe liver disease

Also at risk for bleeding
Thrombocytopenia - platelet sequestration, portal hypertension, hypersplenism
Elevated FDP - poor hepatic clearance
Low synthesis of coagulation factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How to differentiate liver disease and DIC?

A

Lab parameters in liver disease do NOT change rapidly

Look for presence of portal hypertension or signs of underlying liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment of DIC with active bleeding or is at high risk for bleeding?

A

Transfusion of FFP and/or platelet concentrates

- in preparation for surgery or after chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What cutoff platelet level in DIC requires replacement therapy?

A

Platelet <10,000-20,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Low levels of fibrinogen <100mg/dl or brisk hyperfibrinolysis will require infusion of:

A

Cryoprecipitate
(fibrinogen, factor VIII, vWF)

10 U Cryo for every 2-3 U of FFP is sufficient to correct hemostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment of purpura fulminans?

A

Heparin

During surgical resection of tumor or removal of dead fetus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which patients with DIC benefit from antifibrinolytic drugs / tranexamic acid?

A

Acute promyelocytic leukemia
Chronic DIC
Giant hemangioma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Coagulation disorder caused by deficiency in Factor VIII?

A

Hemophilia A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Coagulation disorder caused by deficiency in Factor IX?

A

Hemophilia B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Isolated abnormal prothrombin time suggests deficiency of what factor?

A

Factor VII (Extrinsic pathway)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Prolonged aPTT indicates deficiency in Factors:

A

Factors VIII and IX (Hemophilia) or Factor XI (Intrinsic Pathway)

16
Q

Prolongation of both PT and aPTT indicates deficiency in what factors?

A

Factors V, X, II (Thrombin) and Fibrinogen - Common Pathway

17
Q

Differentiate deficiency vs presence of inhibitor using mixing tests

A

Addition of the missing protein to the plasma of a subject with an inhibitor does NOT correct the abnormal PTT and PT - if there is an inhibitor

18
Q

One of the most common Hemophilia A mutations results from inversion of:

A

Intron 22 sequence

19
Q

What test for coagulation is prolonged (isolated) in patients with Hemophilia?

A

Isolated prolongation of aPTT

Bleeding time and Platelet counts are normal

20
Q

Most common bleeding manifestation in severe hemophilia

A

Recurrent hemarthroses - mainly knees elbows ankles shoulders hips

21
Q

Acute hemarthroses due to bleeding may be painful, patients would tend to adopt a fixed position leading to this complication:

A

Muscle contractures

22
Q

Hematomas into the muscle of patients with hemophilia may lead to:

A

Compartment syndrome

Recurrent bleeding in the joint (target joint) may need surgery

23
Retroperitoneal hemorrhage in hemophilia may form masses of calcification and inflammatory tissue reaction producing:
Pseudotumor Syndrome - results to damage of the Femoral nerve
24
What complication is expected in elderly patients diagnosed and treated for hemophilia in the 1970s
HIV and Hep C infections that may have contaminated blood products that were transfused
25
Factor replacement for hemophilia has emerged in response to bleeding or as prophylaxis. What are the half lives and corresponding dose frequency of Factor VIII and IX?
FVIII half life 8-12 hours, injections BID | FIX half life 24 hours, injections OD
26
What blood product is enriched with FVIII protein and was popularly used as treatment of hemophilia A?
Cryoprecipitate - approximately 80 IU of FVIII
27
Risk of transfusing cryoprecipitate as treatment for hemophilia?
Risks of blood borne diseases increase
28
Prophylactic replacement of factors prior to surgery requires normal factor levels 100% for how many days?
7-10 days
29
Synthetic vasopressin analog that causes transient rise in FVIII and VWD by release from the endothelial cells
DDAVP | Does not improve FVIII levels in severe hemophilia A because there are no stores to release
30
Complication of repeated dosing of DDAVP in Hemophilia?
Tachyphylaxis - mechanism is release of FVIII from endothelial cells vs de novo synthesis CANNOT use DDAVP in Type IIB VWD
31
Contraindication to starting tranexamic acid or any antifibrinolytic drug in preparation for surgery
Hematuria or GU bleed - may risk the formation of occlusive clot in the lumen of the GU tract
32
Major complication of factor replacement therapy in Hemophilia A and B?
Formation of alloantibodies to both FVIII and FIX (inhibitors)
33
Most effective way to eradicate inhibitors to FVIII and FIX:
Immune tolerance induction (ITI) +/- Rituximab (daily infusions for >1 year)
34
Rare inherited platelet disorder with the absence of Platelet IIB/IIIA receptor?
Glanzmann's Thrombasthenia
35
Rare inherited platelet disorder with the absence of platelet IB-IX-V receptor?
Bernard Soulier Syndrome
36
Expected PT PTT results in hemophilia?
PT normal | PTT prolonged
37
Expected PT PTT in DIC?
PT PTT prolonged
38
Expected findings in peripheral smear of DIC
Schistocytes